Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer

Histopathology

Volumn 58, Issue 4, 2011, Pages 571-578

  Seiler, Roland ^a   von Gunten, Michael ^a   Thalmann, George N ^a   Fleischmann, Achim ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bladder cancer; Lymph node metastases; Lymphadenectomy; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CANCER TISSUE; COHORT ANALYSIS; CYSTECTOMY; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 79952716350     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03778.x     Document Type: Article

References (31)

1. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J. Urol. 2001; 166; 19-23.
2. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J. Clin. Oncol. 2001; 19; 666-675.
3. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J. Clin. Oncol. 2005; 23; 2358-2365.
4. Frank I, Cheville JC, Blute ML et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer 2003; 97; 2425-2431.
5. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J. Urol. 2003; 169; 943-945.
6. Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J. Urol. 2001; 165; 62-64.
7. Stein JP, Penson DF, Cai J et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J. Urol. 2007; 177; 876-881.
8. Sobin LH, Wittekind C eds. TNM atlas, 6th edn. New York: Wiley-Lyss, 2002.
9. Lerner SP, Skinner DG, Lieskovsky G et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J. Urol. 1993; 149; 758-764.
10. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J. Urol. 2003; 170; 35-41.
11. Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology 2010; 75; 382-386.
12. Studer UE, Danuser H, Merz VW, Springer JP, Zingg EJ. Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment. J. Urol. 1995; 154; 49-56.
13. Akaike H. A new look at the statistical model identification. EEE Trans. Automat. Contr. 1974; 19; 716-723.
14. Ueno H, Mochizuki H, Hashiguchi Y et al. Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am. J. Clin. Pathol. 2007; 127; 287-294.
15. Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61; 105-108.
16. Vieweg J, Gschwend JE, Herr HW, Fair WR. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J. Urol. 1999; 161; 449-454.
17. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J. Urol. 1996; 156; 1969-1971.
18. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol. 2002; 167; 1295-1298.
19. Vieweg J, Whitmore WF Jr, Herr HW et al. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1994; 73; 3020-3028.
20. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J. Urol. 2008; 179; 873-878.
21. Karl A, Carroll PR, Gschwend JE et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur. Urol. 2009; 55; 826-835.
22. Cascinelli N, Greco M, Bufalino R et al. Prognosis of breast cancer with axillary node metastases after surgical treatment only. Eur. J. Cancer Clin. Oncol. 1987; 23; 795-799.
23. Fleischmann A, Schobinger S, Markwalder R et al. Prognostic factors in lymph node metastases of prostatic cancer patients: the size of the metastases but not extranodal extension independently predicts survival. Histopathology 2008; 53; 468-475.
24. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001; 92; 3030-3036.
25. Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr. Penile cancer: relation of extent of nodal metastasis to survival. J. Urol. 1987; 137; 880-882.
26. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 1997; 80; 2268-2272.
27. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 2005; 104; 1408-1417.
28. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 1993; 72; 778-782.
29. Leonard C, Corkill M, Tompkin J et al. Are axillary recurrence and overall survival affected by axillary extranodal tumor extension in breast cancer? Implications for radiation therapy. J. Clin. Oncol. 1995; 13; 47-53.
30. Mignano JE, Zahurak ML, Chakravarthy A, Piantadosi S, Dooley WC, Gage I. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation. Cancer 1999; 86; 1258-1262.
31. Parisi S, Troiano M, Corsa P et al. Role of external radiation therapy in urinary cancers. Ann. Oncol. 2007; 18(Suppl. 6); 157-161.